Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Zero Based Budgeting For Freelancers helps convert fluctuating earnings into predictable spending, building a solid financial foundation.
15,597 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Peloton reports fresh restructuring amid a stubborn demand slump and rising costs. The destruction peloton continues ...
Wall Street is piling into hydration brands as 'functional hydration' takes hold. The trend follows social media chat...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
Choosing between a broad healthcare ETF and a biotech-focused fund can shape risk, cost, and growth. This guide break...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
A pivotal Nvidia partner just joined the Nasdaq, delivering triple-digit growth with demand for memory and AI workloa...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
Tempo, a Layer 1 blockchain backed by Stripe, has officially launched its mainnet with a sharp focus on AI agent paym...
Colorado unveils a sweeping plan to fix the battery recycling economics problem by funding a statewide recycling prog...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...